RECURSION PHARMACEUTICALS, INC. (RXRX)
About RECURSION PHARMACEUTICALS, INC.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $74.7M
- Net income
- -$644.8M
- Total assets
- $1.5B
- Market cap
- $1.8B
- Gross margin
- 5.0%
- Operating margin
- -867.9%
- Net margin
- -863.4%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $74.7M
- Cost of revenue
- $71.0M
- Gross profit
- $3.7M
- Operating expenses
- $651.9M
- Operating income
- -$648.1M
- Income tax
- -$136.0K
- Net income
- -$644.8M
- EPS (basic)
- $-1.44
- EPS (diluted)
- $-1.44
Balance sheet
- Total assets
- $1.5B
- Current assets
- $812.8M
- Total liabilities
- $343.3M
- Current liabilities
- $147.7M
- Shareholders’ equity
- $1.1B
Cash flow
- Operating cash flow
- -$371.8M
- Investing cash flow
- -$16.9M
- Financing cash flow
- $521.5M
- Net cash flow
- $150.9M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $1.8B
- EPS (diluted)
- $-1.44
- Shares outstanding
- 594.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Apr 16, 2021
Recursion Pharmaceuticals, Inc. (RXRX) Stock Price
- Reported a net loss of $644.8M in FY2025.
- Revenue grew 634% from FY2021 to FY2025.
- Gross margin of 5.0%, net margin -863.4%.
- Trading 56% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review RECURSION PHARMACEUTICALS, INC..
Write a review
News about RECURSION PHARMACEUTICALS, INC.
News & sentiment via Polygon.io
Recursion Pharmaceuticals, Inc.: frequently asked questions
Is Recursion Pharmaceuticals, Inc. an American company?
Recursion Pharmaceuticals, Inc. is a US-based company headquartered in Salt Lake City, Utah, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Recursion Pharmaceuticals, Inc. headquartered?
Recursion Pharmaceuticals, Inc. is headquartered in Salt Lake City, Utah, United States.
Is Recursion Pharmaceuticals, Inc. publicly traded?
Yes — Recursion Pharmaceuticals, Inc. is a publicly traded company. Its stock trades under the ticker symbol RXRX on the NASDAQ.
What does Recursion Pharmaceuticals, Inc. do?
Recursion Pharmaceuticals, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
